Hitesh Sanganee

Hitesh Sanganee

AstraZeneca, Sweden - Södertälje / Sweden
Others
AD Scientific Index ID: 4400295
-
person_outline Hitesh Sanganee's MOST POPULAR ARTICLES
1-) Screening of a library of phage-displayed peptides identifies human bcl-2 as a taxol-binding proteinDJ Rodi, RW Janes, HJ Sanganee, RA Holton, BA Wallace, L MakowskiJournal of molecular biology 285 (1), 197-203, 19993171999
2-) An integrated approach to fragment-based lead generation: philosophy, strategy and case studies from AstraZeneca\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s drug discovery programmesJS Albert, N Blomberg, AL Breeze, AJH Brown, JN Burrows, PD Edwards, ...Current Topics in Medicinal Chemistry 7 (16), 1600-1629, 20071482007
3-) 4-Substituted-5, 5-dimethyl oxazolidin-2-ones as effective chiral auxiliaries for enolate alkylations and Michael additionsSG Davies, HJ SanganeeTetrahedron: Asymmetry 6 (3), 671-674, 19951461995
4-) Asymmetric alkylations using SuperQuat auxiliaries—an investigation into the synthesis and stability of enolates derived from 5, 5-disubstituted oxazolidin-2-onesSD Bull, SG Davies, S Jones, HJ SanganeeJournal of the Chemical Society, Perkin Transactions 1, 387-398, 19991271999
5-) The ‘SuperQuat’(R)-4-phenyl-5, 5-dimethyl oxazolidin-2-one as an effective chiral auxiliary for conjugate additions: Asymmetric synthesis of (−)-Aplysillamide BSG Davies, HJ Sanganee, P SzolcsanyiTetrahedron 55 (11), 3337-3354, 19991021999